Gabriel Information

Gabriel is a medical technology company focused on autonomic health through closed-loop therapeutics. The Gabriel platform integrates objective, contactless physiological sensing, targeted neuromodulation, and an assistive AI operating system to measure, interpret, and modulate autonomic function in real time. The system continuously adapts therapy based on an individual’s physiological response, enabling personalized, data-driven care rather than static treatment protocols. Gabriel’s technology is designed to address conditions characterized by autonomic dysregulation, including stress-related disorders, sleep fragmentation, and PTSD. The platform captures high-resolution autonomic signals—such as heart rate, heart rate variability, respiration, micro-motion, and sleep disruption—and uses those signals to guide non-invasive therapeutic intervention. The company’s approach emphasizes clinical validation, regulatory alignment, and government-first deployment, with early focus on veterans, first responders, and underserved populations. Gabriel operates with a conservative regulatory posture, prioritizing safety, transparency, and measurable outcomes. By closing the loop between sensing and therapy, Gabriel enables a new model of autonomic care: objective, adaptive, and personalized.